Senators question Allergan CEO on tribe patent deal
Por um escritor misterioso
Descrição
A group of five senators said the deal was a "blatant attempt to further Allergan's market monopoly" on its $1.5 billion eye drug, Restasis.
Senators blast Allergan's tribal deal, social contract as 'hypocrisy
Allergan Gains Another Approval for Botox Amid Patent Controversy Over Restasis - Xtalks
Does Allergan's Saint Regis Mohawk Tribe transactional move rip off consumers? - The IPKat
Allergan CEO on patent deal: 'It wasn't desperation, it was tenacity
All eyes on Saint Regis Mohawk Tribe in contentious patent case
Senators question Allergan CEO on tribe patent deal
Allergan does patent deal for Restasis with Native American tribe
Prescription Drug Costs
Notes Archives – Page 4 of 28 – Southern California Law Review
U.S. Senators Press Allergan for Details on Patent Deal With Tribe
Patent transfer to Mohawk tribe intended to stop generic drugs
Allergan Mohawk Tribe Patent Deal
Supreme Court's Arthrex decision creates more review for patent owners — and more questions - Medical Design and Outsourcing
Allergan settles Restasis litigation with Pfizer's InnoPharma as backlash mounts over tribal patent deal
A handful of Allergan's top shareholders want to bring back the old CEO as chairman
de
por adulto (o preço varia de acordo com o tamanho do grupo)
